Published in Eur J Clin Microbiol Infect Dis on February 01, 1997
Early detection of bacterial growth, with carbon-14-labeled glucose. Radiology (1969) 11.05
Evaluation of the BACTEC radiometric method for recovery of mycobacteria and drug susceptibility testing of Mycobacterium tuberculosis from acid-fast smear-positive specimens. J Clin Microbiol (1983) 10.49
Evaluation of rapid radiometric method for drug susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol (1981) 9.67
Comparison of a radiometric method (BACTEC) and conventional culture media for recovery of mycobacteria from smear-negative specimens. J Clin Microbiol (1983) 7.02
Radiometric detection of the metabolic activity of Mycobacterium tuberculosis. J Nucl Med (1975) 5.30
Comparison of MB-Check, BACTEC, and egg-based media for recovery of mycobacteria. J Clin Microbiol (1992) 4.55
Role of solid media when used in conjunction with the BACTEC system for mycobacterial isolation and identification. J Clin Microbiol (1991) 3.60
Detection of mycobacteria by radiometric and standard plate procedures. J Clin Microbiol (1983) 2.85
Comparison of the Septi-Chek AFB and BACTEC systems and conventional culture for recovery of mycobacteria. J Clin Microbiol (1993) 2.58
Detection and recovery of mycobacteria by a radiometric procedure. J Clin Microbiol (1983) 1.92
Comparison of recovery rates for mycobacteria from BACTEC 12B vials, Middlebrook 7H11-selective 7H11 biplates, and Lowenstein Jensen slants in a public health mycobacteriology laboratory. J Clin Microbiol (1995) 1.58
Recovery and survival of nontuberculous mycobacteria under various growth and decontamination conditions. Can J Microbiol (1984) 1.08
Inhibitory effect of rubber on the growth of M. tuberculosis. Tubercle (1980) 0.75
Food and medicaments as possible sources of hospital strains of Pseudomonas aeruginosa. Lancet (1969) 2.79
Nasal acquisition of Staphylococcus aureus in a subdivided and mechanically ventilated ward: endemic prevalence of a single staphylococcal strain. J Hyg (Lond) (1970) 2.48
Plastic isolators for treatment of acute leukaemia patients under "germ-free" conditions. Br Med J (1975) 2.41
Antibiotic resistant tuberculosis in the United Kingdom: 1993-1999. Thorax (2002) 2.12
Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. The EORTC international antimicrobial therapy project group. J Infect Dis (1978) 1.89
Contamination of nurses' uniforms with Staphylococcus aureus. Lancet (1969) 1.64
Methicillin-resistant Staphylococcus aureus: impact at a national cystic fibrosis centre. J Hosp Infect (1998) 1.55
A study of glutaraldehyde disinfection of fibreoptic bronchoscopes experimentally contaminated with Mycobacterium tuberculosis. J Hosp Infect (1992) 1.40
Asymptomatic carriage of Clostridium difficile in patients with cystic fibrosis. J Clin Pathol (1986) 1.38
Changes in gut flora after cephalexin treatment. Br Med J (1970) 1.37
Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer. Antimicrob Agents Chemother (1995) 1.31
Non-tuberculous mycobacteria in patients with bronchiectasis. Thorax (2005) 1.23
Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia. The EORTC International Antimicrobial Therapy Cooperative Group. N Engl J Med (1987) 1.21
Contamination of endoscopes used in AIDS patients. Lancet (1989) 1.21
Prospective randomized comparison of three antibiotic regimens for empirical therapy of suspected bacteremic infection in febrile granulocytopenic patients. Antimicrob Agents Chemother (1986) 1.17
In vitro activity of ciprofloxacin against mycobacteria. Eur J Clin Microbiol (1985) 1.17
Infection control in intensive care. Br J Anaesth (1976) 1.12
Factors associated with bacteraemia in febrile, granulocytopenic cancer patients. The International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC). Eur J Cancer (1994) 1.10
Pseudomonas cepacia: pulmonary infection in patients with cystic fibrosis. Respir Med (1993) 1.09
Treatment of endocarditis with teicoplanin: a retrospective analysis of 104 cases. J Antimicrob Chemother (1996) 1.07
Comparison of a solution of super-oxidized water (Sterilox) with glutaraldehyde for the disinfection of bronchoscopes, contaminated. J Hosp Infect (2000) 1.07
Prospective randomized evaluation of ciprofloxacin versus piperacillin plus amikacin for empiric antibiotic therapy of febrile granulocytopenic cancer patients with lymphomas and solid tumors. The European Organization for Research on Treatment of Cancer International Antimicrobial Therapy Cooperative Group. Antimicrob Agents Chemother (1991) 1.03
The role of Mycobacterium avium complex fibronectin attachment protein in adherence to the human respiratory mucosa. Mol Microbiol (2000) 1.02
Empiric antimicrobial therapy for febrile granulocytopenic cancer patients: lessons from four EORTC trials. Eur J Cancer Clin Oncol (1988) 1.01
Azlocillin compared with carbenicillin in the treatment of bronchopulmonary infection due to Pseudomonas aeruginosa in cystic fibrosis. Thorax (1984) 1.01
Comparison of characteristics of patients and treatment outcome for pulmonary non-tuberculous mycobacterial infection and pulmonary tuberculosis. Thorax (1996) 1.00
Changing patterns of infection in cancer patients. Eur J Cancer (1973) 0.99
Volatile fatty acids in the faeces of patients in 'germ-free' isolation. Gut (1973) 0.98
Comparative in vitro Activity of Cefuroxime and its Interactions with Aminoglycoside Antibiotics. Proc R Soc Med (1977) 0.94
Recovery of the human immunodeficiency virus from fibreoptic bronchoscopes. Thorax (1991) 0.93
A comparison of oral cefuroxime axetil and oral amoxycillin in lower respiratory tract infections. J Antimicrob Chemother (1985) 0.91
Investigation of mycobacterial colonisation and invasion of the respiratory mucosa. Thorax (2003) 0.90
A prospective study of wound infection in coronary artery surgery. Eur J Cardiothorac Surg (1999) 0.90
Nasal application of the cationic liposome DC-Chol:DOPE does not alter ion transport, lung function or bacterial growth. Eur Respir J (1994) 0.90
Vancomycin versus placebo for treating persistent fever in patients with neutropenic cancer receiving piperacillin-tazobactam monotherapy. Clin Infect Dis (2003) 0.89
Why disinfect ventilators? Lancet (1973) 0.88
Letter: Pseudomonas aeruginosa resistant to gentamicin. Lancet (1975) 0.87
Empirical antibiotic therapy in febrile patients with neutropenia and malignant disease. Eur J Cancer (1973) 0.86
Inhibition of adherence of Mycobacterium avium complex and Mycobacterium tuberculosis to fibronectin on the respiratory mucosa. Respir Med (2004) 0.84
Interaction between mycobacteria and mucus on a human respiratory tissue organ culture model with an air interface. Exp Lung Res (2004) 0.84
Interaction of Mycobacterium tuberculosis with human respiratory mucosa. Tuberculosis (Edinb) (2002) 0.83
Temocillin and cystic fibrosis: outcome of intravenous administration in patients infected with Pseudomonas cepacia. J Antimicrob Chemother (1992) 0.83
Antibiotic levels on continuous intravenous infusion. Lancet (1971) 0.82
Double-blind randomized study of prolonged higher-dose oral amoxycillin in purulent bronchiectasis. Q J Med (1990) 0.82
In vitro and in vivo studies of three antibiotic combinations against gram-negative bacteria and Staphylococcus aureus. Antimicrob Agents Chemother (1981) 0.82
Rational basis for the choice of regimens for empirical therapy of sepsis in granulocytopenic patients. Clin Haematol (1984) 0.81
Combination chemotherapy with ciprofloxacin for infection with Mycobacterium tuberculosis in mouse models. Am J Med (1989) 0.81
Disinfection of bronchoscopes, contaminated in vitro with Mycobacterium tuberculosis, Mycobacterium avium-intracellulare and Mycobacterium chelonae in sputum, using stabilized, buffered peracetic acid solution ('Nu-Cidex'). J Hosp Infect (1997) 0.81
Colonisation of lung allografts with Pseudomonas aeruginosa in heart-lung transplant recipients with cystic fibrosis. Thorax (1994) 0.81
An audit into the efficacy of single use bacterial/viral filters for the prevention of equipment contamination during lung function assessment. Respir Med (2005) 0.80
Characteristics of patients with drug resistant and drug sensitive tuberculosis in East London between 1984 and 1992. Thorax (1994) 0.80
Quinolones in the treatment of serious infections. Rev Infect Dis (1988) 0.79
The efficacy of the disinfection of bronchoscopes contaminated in vitro with Mycobacterium tuberculosis and Mycobacterium avium-intracellulare in sputum: a comparison of Sactimed-I-Sinald and glutaraldehyde. J Hosp Infect (1995) 0.78
Bacterial contamination of ward-based computer terminals. J Hosp Infect (2002) 0.78
A new enzyme-linked fluorescence assay (ELFA) for use with peroxidase-antibody conjugates: a comparison with ELISA for the quantitation of IgM antibodies to hepatitis B core antigen. J Med Microbiol (1986) 0.78
Expiratory bacterial filters. Lancet (1976) 0.78
Rapid determination of bacterial susceptibility to antimicrobial agents by a semi-automated continuous flow method. J Antimicrob Chemother (1982) 0.78
Protocol for an international prospective trial of initial therapy regimens in neutropenic patients with malignant disease. Eur J Cancer (1975) 0.78
Reduction of complement activation during bypass by prime manipulation. Ann Thorac Surg (1990) 0.77
The absorption and sputum penetration of doxycycline. J Antimicrob Chemother (1978) 0.77
Rational basis for the choice of regimens for empirical therapy of sepsis in granulocytopenic patients. A report of the EORTC International Antimicrobial Therapy Project Group. Schweiz Med Wochenschr Suppl (1983) 0.76
Complement activation before, during and after cardiopulmonary bypass. Eur J Cardiothorac Surg (1990) 0.75
Viral haemorrhagic fever guidelines. J Hosp Infect (1998) 0.75
Monitoring treatment with aminoglycoside antibiotics. BMJ (1993) 0.75
The use of plastic isolators to prevent infection in neutropenic patients. Postgrad Med J (1976) 0.75
Carbapenems in febrile neutropenic patients. J Antimicrob Chemother (1997) 0.75
Evaluation of products for treating babies' napkins. J Hyg (Lond) (1979) 0.75
Indications for systemic antibiotic prophylaxis in neutropenic patients. Br Med J (1974) 0.75
Use of cephalosporins in the immunologically compromised patient. Drugs (1987) 0.75
Empirical therapy in febrile granulocytopenic patients. Eur J Cancer (1979) 0.75
Sepsis in a CPAP system. Anaesthesia (1976) 0.75
Complement activation during bypass in acquired C1 esterase inhibitor deficiency. Ann Thorac Surg (1991) 0.75
Respiratory filters in clinical practice. Lancet (1974) 0.75
In vitro susceptibility of urinary isolates of Escherichia coli to cinoxacin. J Antimicrob Chemother (1979) 0.75
Evidence against transmission of Pseudomonas aeruginosa by hands and stethoscopes in a cystic fibrosis unit. J Hosp Infect (2002) 0.75
In vitro activity of temocillin against gram-negative clinical isolates. Drugs (1985) 0.75
Hexachlorophane teratogenicity in rats. Lancet (1972) 0.75
Disinfection of the East-Radcliffe ventilator. A bacteriological study of a modified picloxydine technique. Anaesthesia (1969) 0.75
Proceedings: Bacterial filters for mechanical ventilators. Br J Anaesth (1974) 0.75
Decontamination of the Cape Ventilator. A method using Savlon and isopropyl alcohol. Anaesthesia (1969) 0.75
Letter: Respiratory filters in clinical practice. Lancet (1974) 0.75
A new approach to the treatment of Xanthomonas maltophilia respiratory infection in a patient with cystic fibrosis. Respir Med (1998) 0.75
Use of statistical methods in the rapid determination of antimicrobial susceptibilities of Escherichia coli. J Antimicrob Chemother (1982) 0.75
Laboratory support for choosing and monitoring antimicrobial therapy in severely ill patients. Am J Med (1986) 0.75
Cefotaxime and amikacin: results of in vitro and in vivo studies against Gram-negative bacteria and Staphylococcus aureus. EORTC International Antimicrobial Therapy Project Group. J Antimicrob Chemother (1980) 0.75
Prospective randomly controlled trial of three antibiotic combinations for empirical therapy of suspected sepsis in neutropenic cancer patients. Eur J Cancer (1975) 0.75